RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
TADAX
Price
$28.59
Change
-$0.43 (-1.48%)
Updated
Jun 13 closing price
Net Assets
2.55B
Interact to see
Advertisement

RGAGX vs TADAX

Header iconRGAGX vs TADAX Comparison
Open Charts RGAGX vs TADAXBanner chart's image
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
Transamerica US Growth A
Price$28.59
Change-$0.43 (-1.48%)
VolumeN/A
Net Assets2.55B
RGAGX vs TADAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAGX vs. TADAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAGX is a Buy and TADAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. TADAX (2.55B). RGAGX pays higher dividends than TADAX: RGAGX (0.65) vs TADAX (0.00). RGAGX was incepted earlier than TADAX: RGAGX (16 years) vs TADAX (16 years). TADAX (1.03) is less costly to investors than RGAGX (0.30). TADAX is a more actively managed with annual turnover of: 36.00 vs. RGAGX (25.00). RGAGX has a lower initial minimum investment than TADAX: RGAGX (250) vs TADAX (1000). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. TADAX (-4.60). RGAGX return over 5 years is better than : 51.11 vs. TADAX (24.30).
RGAGXTADAXRGAGX / TADAX
Total Expense Ratio0.301.0329%
Annual Report Gross Expense Ratio0.301.0329%
Fund Existence16 years16 years-
Gain YTD5.2050.3161,648%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets306B2.55B12,019%
Annual Yield % from dividends0.650.00-
Returns for 1 year7.67-4.60-167%
Returns for 3 years54.6643.02127%
Returns for 5 years51.1124.30210%
Returns for 10 years75.6267.19113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo